Free Trial

Brandywine Global Investment Management LLC Takes $4.49 Million Position in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Brandywine Global Investment Management LLC bought a new position in shares of Genpact Limited (NYSE:G - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 104,629 shares of the business services provider's stock, valued at approximately $4,494,000. Brandywine Global Investment Management LLC owned 0.06% of Genpact as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Stifel Financial Corp bought a new stake in shares of Genpact in the third quarter valued at about $1,197,000. Blue Trust Inc. raised its stake in Genpact by 8.7% in the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock worth $217,000 after purchasing an additional 441 shares in the last quarter. Burney Co. boosted its holdings in Genpact by 242.8% in the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider's stock valued at $5,618,000 after purchasing an additional 92,641 shares during the period. KBC Group NV acquired a new position in shares of Genpact during the 4th quarter worth approximately $298,000. Finally, JPMorgan Chase & Co. increased its holdings in shares of Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock worth $122,701,000 after purchasing an additional 2,060,595 shares during the period. Institutional investors and hedge funds own 96.03% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and boosted their price target for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Needham & Company LLC upped their target price on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Mizuho raised their price target on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research report on Monday, February 10th. Finally, Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price objective for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. Six analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and an average price target of $48.44.

Read Our Latest Report on G

Insider Activity

In other news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Piyush Mehta sold 12,000 shares of the business's stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares in the company, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is owned by corporate insiders.

Genpact Price Performance

Shares of G stock traded down $1.83 on Friday, hitting $47.08. 2,182,743 shares of the company's stock were exchanged, compared to its average volume of 1,347,002. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The company has a 50 day moving average of $51.20 and a 200 day moving average of $45.49. The stock has a market cap of $8.27 billion, a P/E ratio of 16.58, a price-to-earnings-growth ratio of 1.84 and a beta of 1.06.

Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, equities research analysts predict that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were issued a dividend of $0.17 per share. The ex-dividend date of this dividend was Tuesday, March 11th. This is an increase from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a dividend yield of 1.44%. Genpact's dividend payout ratio is 23.94%.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Read More

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines